You are here: Industry Insights > esophageal cancer

News List

Model May Predict Barrett Esophagus Diagnosis in GERD Patients drugs
December 26, 2019
A diagnostic model can help predict diagnosis of Barrett esophagus in patients with symptomatic gastroesophageal reflux disease, according to a study published online in The Lancet Digital Health.
Keytruda cuts risk of death by 31% in esophageal cancer trial pharmaphorum
January 16, 2019
MSD’s Keytruda has cut the risk of death by 31% in patients with esophageal or esophagogastric junction carcinoma or adenocarcinoma who progressed after standard therapy.
Merck's Keytruda slashes death risk by 31% in esophageal cancer victory fiercepharma
January 15, 2019
Back in November, Merck & Co. said its immuno-oncology star, Keytruda, had topped chemo at lengthening the lives of some esophageal cancer patients. Monday, it showed that the win was a sizable one.
Merck's Keytruda picks up first-in-class survival win in esophageal cancer fiercepharma
November 15, 2018
Merck’s Keytruda is looking to beat its immuno-oncology rivals into yet another market, and it just posted the data that could get the job done.
Merck's Keytruda picks up first-in-class survival win in esophageal cancer fiercepharma
November 15, 2018
Merck’s Keytruda is looking to beat its immuno-oncology rivals into yet another market, and it just posted the data that could get the job done.